APatinib Plus Chemotherapy vErsus Chemotherapy As First-line Treatment for Advanced NSCLC
Status:
Unknown status
Trial end date:
2020-05-20
Target enrollment:
Participant gender:
Summary
The purpose of this study is to studying the addition of apatinib with chemotherapy to
investigate the efficacy and safety of apatinib in combination with chemotherapy in patients
with advanced NSCLC.